Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients

The COVID-19 pandemic continues to be a worldwide health issue. Among hemodialysis (HD) patients, two-dose immunization schemes with mRNA vaccines have contributed to preventing severe COVID-19 cases; however, some have not produced a sufficient humoral response, and most have developed a rapid decl...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	José Jesús Broseta, Diana Rodríguez-Espinosa, Elena Cuadrado, Néstor Rodríguez, José Luis Bedini, Francisco Maduell
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Subjects:	antibody formation immunogenicity SARS-CoV-2 COVID-19 COVID-19 vaccines mRNA vaccines
Online Access:	https://www.mdpi.com/2076-393X/10/4/522